Treatment
Medication clinical trials
We’re tracking 7,450 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT03306082Enrolling by invitation
Test whether guided programming improves cochlear implant settings
This study checks whether an imaging-guided method can help tune your cochlear implant to improve hearing performance compared with the usual programming approach. It mainly looks at adults who already have a cochlear implant and have shown expected improvements with standard setup.
Nashville, TennesseeAges 18–90 - NCT07142798Enrolling by invitation
14-day triple therapy for H. pylori infection
This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.
Kaohsiung CityAges 18–80 - NCT06243315Enrolling by invitation
Long-term safety study of Ellansé-S filler for smile lines
This study tests the long-term safety of a dermal filler called Ellansé-S, which is made of small PCL microspheres. It is for people who want to treat moderate to deep lines from the nose to the corners of the mouth.
Guangzhou, GuangdongAges 18 years+ - NCT03516461Recruiting
Fecal transplant study for bowel injury after radiation
This study tests whether transferring stool bacteria (a fecal microbiota transplant) can improve “radiation enteritis,” a bowel problem that happens after radiation treatment. It may help restore gut bacteria and reduce symptoms after your radiation therapy.
Nanjing, JiangsuAges 18–85 - NCT03645460Recruiting
Gene therapy for ADA-SCID using a modified virus vector
This trial tests a gene therapy made to help people with ADA-SCID (an inherited immune condition caused by a faulty ADA gene). The goal is to improve immune function and reduce severe infections by delivering a working ADA gene into the patient’s own cells.
Shenzhen, GuangdongAges 1 month+ - NCT07154576Enrolling by invitation
Pelvic floor symptoms and pain sensitivity study
This study looks at how pain sensitivity relates to pelvic floor problems in women. It uses questionnaires to gather information and may help improve understanding of these conditions.
WarsawAges 18–80 - NCT06205862RecruitingPhase 2
Fecal transplant for preventing colon polyp return
This study tests whether taking capsules of healthy bacteria (fecal microbiota transplant) can help prevent colon polyps from coming back after they have been removed. It might be an option for people who have had an adenoma polyp removed and want to reduce the chance of recurrence.
Guangzhou, GuangdongAges 18–75 - NCT06524531RecruitingEarly Phase 1
Pulse Energy and Blood Injection for Stubborn Back Pain
This trial tests a new treatment for stubborn low back pain that involves a short pulse of radio waves (a type of energy) and an injection of your own blood cells (called PRP) to help the muscles in your back work better. It is for people whose pain comes from a specific muscle problem and has not gone away with other care.
Lahore, Punjab ProvinceAges 30–70 - NCT06472037RecruitingPhase 2
AG chemo plus immunotherapy and short radiation for locally advanced pancreatic cancer
This trial tests a combination of two chemotherapy drugs (AG) plus an immunotherapy (cadonilimab) and a short course of radiation for people with locally advanced pancreatic cancer that hasn't been treated yet. The goal is to see if this approach helps shrink or control the tumor.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06470347RecruitingPhase 1/Phase 2
Testing Pyrrolitinib After Trastuzumab for HER2+ Breast Cancer
This study tests if taking pyrrolitinib (a targeted medicine) can further reduce the risk of breast cancer returning in patients with HER2-positive early breast cancer who have already received trastuzumab after surgery.
Zunyi, GuizhouAges 18–75 - NCT07656753RecruitingEarly Phase 1
Gene therapy trial for RLBP1-related retinal dystrophy
This trial tests an injection (PUMCH-E111) for people with a specific genetic form of inherited retinal dystrophy caused by RLBP1 mutations. It aims to see if the treatment is safe and can help preserve vision.
Beijing, Beijing MunicipalityAges 18–55 - NCT05289245Recruiting
Registry study for Chinese people with cystic fibrosis
This study keeps a national record of people diagnosed with cystic fibrosis (CF) in China. It aims to better understand CF over time and may help future care by improving how patients are tracked and studied.
Beijing, Beijing MunicipalityAges Any age - NCT06464198Recruiting
Radiation and chemo after surgery for salivary gland cancer
This study tests giving radiation and chemotherapy together after surgery for aggressive salivary gland cancers of the head and neck. It aims to see how well this standard treatment works in real-world settings.
ErlangenAges 18–99 - NCT06471907Recruiting
Comparing pain relief and blood flow during back injections
This study tests a new way to give a pain-relieving injection for lower back problems. If you have ongoing back pain from a disc, narrowing, or slipped bone, this treatment may help reduce your pain.
DaeguAges 20–80 - NCT06507059RecruitingPhase 3
Injectable HIV treatment trial for people with unsuppressed virus
This trial tests if switching to a long-acting injectable medication can help people with HIV who have trouble keeping their virus suppressed with daily pills. You would receive shots in the buttocks every few months instead of taking pills every day.
KeelungAges 18 years+ - NCT06202443Recruiting
Physical therapy timing after neck surgery
This study looks at whether starting physical therapy soon after ACDF neck surgery helps people recover better. It compares early physical therapy to standard care.
Honolulu, HawaiiAges 18–75 - NCT02438631Recruiting
Study how drugs pass from placenta to baby
This study looks at how certain medicines move from a pregnant person’s placenta to the baby and what happens to them. It may help improve how medicines are used during late pregnancy and childbirth.
Nijmegen, GelderlandAges 18 years+ - NCT06477458Recruiting
AI analysis of CT scans for lung health before chest surgery
This study uses a computer program (deep learning) to analyze your chest CT scan and lung function test results before surgery. The goal is to see if the AI can help doctors better assess your lungs and plan your operation.
Guangzhou, GuangdongAges 18–75 - NCT06489197RecruitingPhase 2
AK112 plus chemo for advanced esophageal cancer
This trial tests a new immunotherapy drug (AK112) combined with chemotherapy as a first treatment for advanced esophageal cancer that has spread or cannot be removed. It aims to see if this combination helps shrink tumors and controls the disease longer than chemotherapy alone.
Tianjin, Tianjin MunicipalityAges 18–75 - NCT06492980Recruiting
Stent graft for acute type I aortic dissection repair
This trial tests a special stent graft for people with a sudden tear in the inner layer of the aorta (type I aortic dissection) that needs urgent repair. It aims to see if the device can help treat the condition safely.
Fuzhou, FujianAges 20–65 - NCT07173868Recruiting
PET scans for advanced breast cancer treatment planning
This trial tests whether a special PET scan (FDG PET-CT) can better track how well treatment is working for people with advanced breast cancer. It may help doctors choose the best therapy and monitor response over time.
Seoul, Gannam-guAges 19 years+ - NCT05518604Recruiting
Weight loss and fitness after pregnancy in active-duty women
This study looks at how to support healthy weight loss and physical fitness after having a baby while you’re still on active duty. It may help by testing a structured approach to fitness and planning during the first 18 months after delivery.
Honolulu, HawaiiAges 18–44 - NCT04834518Recruiting
Screening children for early signs of type 1 diabetes
This study checks for specific blood markers (“islet autoantibodies”) to find children who may be at risk for developing type 1 diabetes later, before symptoms start. It’s mainly for children who have no known diabetes yet.
BeershebaAges 9 months–5 years - NCT06467565RecruitingPhase 2
NALIRIFOX chemotherapy for locally advanced pancreatic cancer
This trial tests a combination of chemotherapy drugs (NALIRIFOX) as a first treatment for people with locally advanced pancreatic cancer that hasn't spread. The goal is to see if it can shrink the tumor and improve outcomes.
Nanjing, JiangsuAges 18–70
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,450 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.